A new study shows promising results for treating certain cancers with immunotherapy and completely avoiding surgery, ...

Michael Wolff was at the "edge of a cliff" when he was diagnosed with a cancer that affects less than 300 patients a year in ...

Some people with early stage cancers may be able to skip surgery after being treated with the immunotherapy drug dostarlimab, ...

The Marie-Josée and Henry R. Kravis Center for Molecular Oncology (CMO) is a team of laboratory, computational, and clinical researchers at Memorial Sloan Kettering working together to translate new ...

According to the results of a new study in the New England Journal of Medicine, 92% of patients who took this drug were cancer-free after two years.

Memorial Sloan Kettering Cancer Center is set to receive ... Kettering's behalf by the Dormitory Authority of the State of New York. The bonds are special limited obligations of the authority ...

Oncology leaders from Alliance Cancer Specialists, American Oncology Network, CHI St. Vincent, Memorial Sloan Kettering ...

HealthCare has opened a new cancer center in partnership with New York City-based Memorial Sloan Kettering Cancer Center. Through the partnership, physicians at the Hartford HealthCare Fairfield ...

the head of solid tumor oncology at Memorial Sloan Kettering Cancer Center in New York City. “One can overcome that, and ...

A first-of-its-kind cancer center opened in Fairfield on Friday. Hartford Healthcare hosted a grand opening ceremony for the ...

With a 95% retention rate for nurse residents completing the program and a 100% 2-year post-hire retention rate, these initiatives ensure a stable and well-trained workforce.

Philadelphia-based Jefferson Health has named Michael Harrington its new executive vice president and CFO. Mr. Harrington joins the system from New York City-based Memorial Sloan Kettering Cancer ...